GV Prasad VC & CEO, Dr Reddy Laboratories explains to CNBC-TV18 that the reason for company‘s good performance for the quarter is the robust growth in the US, Russia and the API business
first published: May 11, 2012 05:48 pm
A collection of the most-viewed Moneycontrol videos.

Fed Leaves Rates Unchanged; Can The Nifty Extend Gains For Third Day?

MC-Deloitte CXO survey | CXOs share their insights on the Indian economy and budget 2026-27

Nifty Reclaims 25,300 Amoid Volatile Session; Midcaps Shine| Closing Bell Live

LIVE: Trump's Climbdown, India-EU FTA, And The Need To Engage With Pakistan With Shyam Saran
You are already a Moneycontrol Pro user.